March 2026 in “Skin Appendage Disorders” Pediatric hair care presents unique challenges due to physiological and structural differences between children's and adults' hair and scalp, necessitating evidence-based approaches. This review highlights key aspects such as lower sebum production, age-related changes in hair density, and structural variability among hair types, which affect product interaction with hair and scalp. Safety concerns include ocular tolerance, allergen potential, and endocrine-disrupting chemicals, with limited research on cumulative exposure and long-term effects. The review emphasizes the need for gentle formulations with controlled pH and minimal irritants, and calls for clearer regulations and more child-focused research, as current cosmetic regulations lack age-specific policies.
96 citations
,
September 2021 in “International Journal of Molecular Sciences” Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.
89 citations
,
November 2014 in “International Journal of Nanomedicine” Using nanostructured lipid carriers to deliver spironolactone could improve treatment for hair loss.
38 citations
,
November 2016 in “Aaps Pharmscitech” Nanoparticles with more oleic acid improved the delivery and stability of the drug spironolactone.
9 citations
,
May 2020 in “Journal of Pharmaceutical and Biomedical Analysis” Method measures latanoprost and minoxidil in skin accurately and precisely.